Position in BBIO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$42,267,306
-$1,307,517 QoQ
Shares Held
569,180
-0.1% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRIMECAP MANAGEMENT CO/CA/ holds $3,436,828,710 across 16 Biotechnology names. BBIO ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
4,975,181 | $1,477,479,501 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
14,194,005 | $801,819,342 | |
| 3 | BNTX |
BioNTech SE
|
3,793,711 | $337,185,033 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,417,509 | $297,220,757 | |
| 5 | XNCR |
Xencor Inc
|
10,338,022 | $124,676,545 | |
| 6 | IMCR |
Immunocore Holdings plc
|
3,693,241 | $111,351,216 | |
| 7 | IMNM |
Immunome Inc.
|
4,788,231 | $104,718,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
569,180 | $42,267,306 |
All Filings in BBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,267,306 | 569,180 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $43,574,823 | 569,680 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $29,936,657 | 576,370 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,420,497 | 588,710 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $31,569,324 | 913,200 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $25,121,320 | 915,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $23,085,193 | 906,724 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $23,478,377 | 926,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $28,669,951 | 927,230 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $38,109,280 | 944,000 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $24,753,519 | 938,700 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,972,782 | 696,092 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,269,067 | 739,992 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,959,285 | 913,292 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,315,036 | 1,037,730 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,559,696 | 1,052,830 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $11,493,352 | 1,132,350 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $17,526,343 | 1,050,740 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $21,600,508 | 460,860 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,240,585 | 446,860 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $21,882,599 | 355,237 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||